Immune System Diseases
📧 Sign up to get email alerts when something new happens for Immune System Diseases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
This entry describes a National Institute of Allergy and Infectious Diseases clinical trial investigating how eosinophils activate and funct…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
This update notes ongoing recruitment for a study collecting immunology specimens from healthy volunteers and patients with various hematolo…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
A clinical trial from University Hospital, Toulouse aims to predict development, progression, or complications of kidney, immune, and transp…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma [Phase 1]
Phase 1 clinical trial update of anti-CD19 CAR-T cells with an inducible caspase-9 safety switch for B-cell lymphoma, currently active but n…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Immuno-Oncology Database and Bioregistry
A research note describing updates to the Immuno-Oncology Database and Bioregistry at UNC Lineberger, including sponsor and conditions invol…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-01-29Clinical Trial Update: Retroviral Insertion Site Methodology Study [Phase 4]
A Phase 4 clinical trial investigating retroviral insertion site methodology for immune system diseases was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-04-21Clinical Trial Update: A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma [Phase 3]
A Phase 3 trial combining Zilovertamab with Ibrutinib for relapsed or refractory mantle cell lymphoma has been withdrawn.
-
EMA approval · 2022-05-24EMA Authorised: Amifampridine SERB (amifampridine phosphate) — SERB SA
European Medicines Agency authorises amifampridine phosphate (SERB) for various neuromuscular and autoimmune conditions, with Lambert-Eaton …
-
CLINICAL_TRIALS trial_result · 2022-05-05Clinical Trial Update: Determination of the Sensitivity and Specificity of Prick Test Betula Verrucosa [Phase 2]
Phase 2 trial evaluating the sensitivity and specificity of the prick test to Betula verrucosa (birch pollen).
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Oral Colostrum and Its Effect on Immune System [Phase 3]
Phase 3 clinical trial update evaluating oral colostrum and its effect on the immune system, with conditions including immune system disease…
-
CLINICAL_TRIALS trial_result · 2018-01-16Clinical Trial Update: Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT [Phase 2]
Phase 2 trial evaluating post-transplant cyclophosphamide as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell …
-
CLINICAL_TRIALS trial_result · 2017-12-26Clinical Trial Update: Asthma Data Innovation Demonstration Project [NA]
Clinical trial update for an asthma-focused data innovation demonstration project; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-04-14Clinical Trial Update: Zoster Vaccine Response in the Frail Elderly
Clinical trial update on zoster vaccine response in frail elderly participants completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2016-08-23Clinical Trial Update: The Effect of Different Volumes of Physical Exercise on the Immune System [NA]
This entry notes the completion of a clinical trial assessing how different volumes of physical exercise affect the immune system, with resu…